Clinical Trial

A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Moderate or Severe Hepatic Impairment

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This study will be conducted to assess the safety and pharmacokinetics of INCB123667 when administered orally to adult participants with moderate or severe hepatic impairment.
Protocol Amendment History 2 changes
critical Recruitment opened 2026-06-17
notable Trial sites expanded: 0 -> 4 locations 2026-06-17
Trial Details
NCT Number NCT07559474
Lead Sponsor Incyte Corporation
Conditions Hepatic Insufficiency, Liver Diseases
Enrollment 16 participants
Start Date 2026-05-27
Primary Completion 2027-04-13 (estimated)
Study Completion 2027-04-13 (estimated)
Updated on ClinicalTrials.gov 2026-06-16